Hypha Labs, Inc.
Hypha Labs, Inc., engages in the research, development, and commercialization of a bioreactor in the United States. It offers Hypha Micropearl bioreactor, a home appliance designed to accelerate the production of beneficial mushrooms for human consumption. Hypha Labs, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada.
Hypha Labs, Inc. (FUNI) - Total Liabilities
Latest total liabilities as of December 2025: $2.74 Million USD
Based on the latest financial reports, Hypha Labs, Inc. (FUNI) has total liabilities worth $2.74 Million USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Hypha Labs, Inc. - Total Liabilities Trend (2011–2025)
This chart illustrates how Hypha Labs, Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Hypha Labs, Inc. Competitors by Total Liabilities
The table below lists competitors of Hypha Labs, Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Aspen Group Inc
OTCQB:ASPU
|
USA | $55.59 Million |
|
Renforth Resources Inc
PINK:RFHRF
|
USA | $747.71K |
|
Dune Acquisition Corporation II Warrants
NASDAQ:IPODW
|
USA | $5.83 Million |
|
Herbal Dispatch Inc.
F:HA9
|
Germany | €8.12 Million |
|
CA Sales Holdings Ltd.
JSE:CAA
|
South Africa | ZAC2.51 Billion |
|
Vision Lithium Inc
OTCQB:ABEPF
|
USA | $1.61 Million |
|
Design Co. Ltd
KQ:227100
|
Korea | ₩129.28 Billion |
|
Trident Gold Corp.
V:TTG
|
Canada | CA$221.61K |
Liability Composition Analysis (2011–2025)
This chart breaks down Hypha Labs, Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.24 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.17 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 7.00 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hypha Labs, Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hypha Labs, Inc. (2011–2025)
The table below shows the annual total liabilities of Hypha Labs, Inc. from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | $2.51 Million | +76.87% |
| 2024-09-30 | $1.42 Million | -56.70% |
| 2023-09-30 | $3.28 Million | -19.64% |
| 2022-09-30 | $4.08 Million | +38.81% |
| 2021-09-30 | $2.94 Million | +2.22% |
| 2020-09-30 | $2.88 Million | +209.39% |
| 2019-09-30 | $930.07K | +141.81% |
| 2018-09-30 | $384.63K | +134.53% |
| 2017-09-30 | $164.00K | -22.61% |
| 2016-09-30 | $211.91K | +34.83% |
| 2015-09-30 | $157.18K | -17.67% |
| 2014-09-30 | $190.90K | -76.21% |
| 2013-09-30 | $802.26K | +29.98% |
| 2012-09-30 | $617.20K | +152.32% |
| 2011-09-30 | $244.61K | -- |